Assessing the Tendons With Shear Wave Elastography
Assessing the Efficacy of the Treatment of Tendinopathy With Shear Wave Elastography
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to utilize Shear Wave Elastography (SWE) to study the viscoelastic properties of tendons to understand the functional differences between normal/asymptomatic and symptomatic tendon states. The study will also assess the degree of tendon healing following standard of care treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2018
CompletedFirst Submitted
Initial submission to the registry
March 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
August 14, 2025
July 1, 2025
8.3 years
March 2, 2018
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Viscoelastic Tendon Property
Shear wave elastography imaging will be used to establish baseline measurements of viscoelastic properties of tendons, such as the Achilles, patellar, quadriceps, epicondylar, and rotator cuff, among asymptomatic and symptomatic patients.
Baseline
Change in Tendon Healing
The degree of tendon healing among symptomatic patients receiving standard of care treatment will be assessed by examining stiffness changes measured by shear wave imaging.
Baseline, Month 3, Month 6, Month 12
Change in Victorian Institute of Sport Assessment - Achilles (VISA-A) Score
Participants symptomatic for Achilles tendinopathy who received standard of care treatment will be asked to complete the VISA-A scale. The VISA-A scale assesses the severity of chronic Achilles tendinopathy. This 8-item, self-administered questionnaire asks about Achilles tendon pain, daily living function, and sporting activity. Total scores can range from 0 to 100, with 0 representing worst pain and function and 100 signifying no pain or limitations to function. Scores below 70 indicate the presence of Achilles tendinopathy.
Month 6, Month 9, Month 12
Change in Victorian Institute of Sport Assessment - Patellar Tendon (VISA-P) Score
Participants symptomatic for patellar tendinopathy who received standard of care treatment will be asked to complete the VISA-A scale. The VISA-P scale assesses patellar tendinosis. This 8-item, self-administered questionnaire asks about symptoms, pain, function, and sporting activity. Total scores can range from 0 to 100, with 0 representing worst pain and function and 100 signifying no pain or limitations to function.
Month 6, Month 9, Month 12
Change in The Foot & Ankle Disability Index (FADI) Score
The FADI is a self-report instrument assessing function related to the foot and ankle. The FADI has 26 items that are scored on a 5-point scale where 0 = unable to do and 4 = no difficulty at all. Total raw scores range from 0 to 104 and scores are converted to percentages, where 100% indicates no dysfunction. This instrument is administered to symptomatic patients receiving standard of care treatment.
Month 6, Month 9, Month 12
Change in The Foot & Ankle Disability Index (FADI) Sport Score
The FADI Sport is a self-report instrument assessing function related to the foot and ankle in athletes. The FADI Sport has 8 items that are scored on a 5-point scale where 0 = unable to do and 4 = no difficulty at all. Total raw scores range from 0 to 32 and scores are converted to percentages, where 100% indicates no dysfunction. This instrument is administered to symptomatic patients receiving standard of care treatment.
Month 6, Month 9, Month 12
Study Arms (2)
Shear Wave Elastography for Asymptomatic Volunteers
Patients with extremity pain but without tendon involvement will have tendon imagining using shear wave elastography.
Shear Wave Elastography Symptomatic Volunteers
Patients diagnosed with tendinopathy will have tendon imagining using shear wave elastography. Participants may have the option to have repeated imaging to examine tendon healing for up to a year after receiving standard of care treatment.
Interventions
An ultrasound (US) technique, known as shear wave elastography (SWE), is used to examine structure and biomechanical function. The examination takes place in the ultrasound room at the study site and lasts for approximately 20 minutes.
Eligibility Criteria
Patients at the Emory Orthopaedics and Spine Center who are asymptomatic or symptomatic for tendinopathy.
You may qualify if:
- Patients presenting at the study location with lower extremity pain without tendon involvement
- Patients presenting at the study location with a clinical diagnosis of tenalgia
- Diagnosis of tendinopathy confirmed by ultrasound
You may not qualify if:
- Pregnancy
- History of tendinopathy or surgery and morphologic abnormalities
- History of systemic, metabolic, endocrine diseases, or psoriasis
- History of treatment with corticosteroids, estrogens, long term quinolone antibiotics, and cholesterol drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Emory Orthopaedics and Spine Center
Atlanta, Georgia, 30329, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Reiter, PhD
Emory University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 2, 2018
First Posted
March 7, 2018
Study Start
February 27, 2018
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
August 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share